Prior to starting Destum Partners, Gareth worked for major financial institutions such as Morgan Stanley and Smith Barney. Throughout his career, Gareth has worked with companies pushing the envelopes of science, technology, and commercial strategy. He has worked with a wide array of companies ranging from start-ups to major pharma.Gareth has completed approximately $2B worth of licensing and M&A transactions. Recently, Gareth led the successful out license Pracinostat from MEI Pharma to Helsinn SA in a deal worth over $465M. He has represented Destum Partners in several deals including: Deals on behalf of Advaxis, Inc., Antisense Therapeutics & Cortendo, Athersys & Chugai, Wilex & Link Health Group, and Diamyd & OMJPI (J&J).In addition, Gareth plays a critical role in managing multiple engagements within Destum Partners consulting practice. Gareth has provided strategic guidance to a variety of companies including UCB Pharma, Pieris AG, Cempra Pharmaceuticals, Arena Pharmaceuticals, Advaxis, and several others.